Targeted medicines: how pharmacists can lead a pharmacogenomics revolution

David Wright; Dhiren Bhatt

Targeted medicines: how pharmacists can lead a pharmacogenomics revolution

David Wright
, Dhiren Bhatt

Research output: Contribution to journal › Comment/debate

2 Citations (Scopus)

Abstract

Though commonplace in other countries, pharmacogenomic testing is yet to become a mainstay of NHS healthcare. Here, David Wright and Dhiren Bhatt argue how this process could improve the chance of therapeutic success and why pharmacists should be at the heart of its implementation.

Original language	English
Pages (from-to)	162-164
Number of pages	3
Journal	Clinical Pharmacist
Volume	10
Issue number	6
Publication status	Published - 6 Jun 2018

Keywords

pharmacogenomics
pharmacy

Access to Document

https://www.pharmaceutical-journal.com/opinion/insight/targeted-medicines-how-pharmacists-can-lead-a-pharmacogenomics-revolution/20204938.article

Cite this

@article{8d9896f2dffc4c76b2967fe9b46eb616,

title = "Targeted medicines: how pharmacists can lead a pharmacogenomics revolution",

abstract = "Though commonplace in other countries, pharmacogenomic testing is yet to become a mainstay of NHS healthcare. Here, David Wright and Dhiren Bhatt argue how this process could improve the chance of therapeutic success and why pharmacists should be at the heart of its implementation.",

keywords = "pharmacogenomics, pharmacy",

author = "David Wright and Dhiren Bhatt",

year = "2018",

month = jun,

day = "6",

language = "English",

volume = "10",

pages = "162--164",

journal = "Clinical Pharmacist",

publisher = "Royal Pharmaceutical Society of Great Britain",

number = "6",

}

TY - JOUR

T1 - Targeted medicines: how pharmacists can lead a pharmacogenomics revolution

AU - Wright, David

AU - Bhatt, Dhiren

PY - 2018/6/6

Y1 - 2018/6/6

N2 - Though commonplace in other countries, pharmacogenomic testing is yet to become a mainstay of NHS healthcare. Here, David Wright and Dhiren Bhatt argue how this process could improve the chance of therapeutic success and why pharmacists should be at the heart of its implementation.

AB - Though commonplace in other countries, pharmacogenomic testing is yet to become a mainstay of NHS healthcare. Here, David Wright and Dhiren Bhatt argue how this process could improve the chance of therapeutic success and why pharmacists should be at the heart of its implementation.

KW - pharmacogenomics

KW - pharmacy

M3 - Comment/debate

VL - 10

SP - 162

EP - 164

JO - Clinical Pharmacist

JF - Clinical Pharmacist

IS - 6

ER -